2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as 2L / 3L Treatment Options?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
0 views
August 13, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
Skin
12:19
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Melanoma: How Effective Is the Combination o…

Feat. M. Orloff
08:06
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND…

Feat. M. Orloff
04:41
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as …

Feat. M. Orloff
13:04
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Metastatic Melanoma: Is Toripalimab + Axitinib a…

Feat. M. Orloff